{
  "id": 20499078,
  "title": "RA Capital Management, PepGen director, buys $43.1 million in stock",
  "url": "https://urgent.news/2026/11/17/ra-capital-management-pepgen-director-buys-43-1-million-in-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-17T21:31:07.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/ra-capital-management-pepgen-director-buys-431-million-in-stock-93CH-5034093"
  },
  "original_language": "en",
  "account": "Boston – RA Capital Management, L.P., a prominent investor in the biotech sector, has bolstered its position in PepGen Inc. (NASDAQ:PEPG) by acquiring an additional 8.6 million shares on November 13, 2026. The investment, valued at $43.1 million, follows a purchase price of $5.0 per share, a price currently lower than the stock's market value of $3.88. Notably, PepGen's stock has surged by 170% over the past six months, indicating strong potential. Despite the current undervaluation, the company's financial health appears robust, with more cash assets than debt. RA Capital Management, L.P. indirectly owns 27.2 million shares through its RA Capital Healthcare Fund, L.P., alongside 1.3 million and 207,672 shares held by RA Capital Nexus Fund II, L.P., and a separately managed account, respectively. The firm's general partner and managing members have disclaimed beneficial ownership of the reported securities, except for their financial stake. RA Capital Management, L.P.'s executive Joshua Resnick also serves on PepGen's board of directors.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}